Prognostic significance of residual mass at the end of therapy in Group III rhabdomyosarcoma (RMS): Intergroup Rhabdomyosarcoma Study (IRS). IV experience Meeting Abstract
| Authors: | Hawkins, D. S.; Stoner, J.; Kao, S.; Rodeberg, D.; Hayes-Jordan, A.; Qualman, S.; Wolden, S.; Meyer, W. |
| Abstract Title: | Prognostic significance of residual mass at the end of therapy in Group III rhabdomyosarcoma (RMS): Intergroup Rhabdomyosarcoma Study (IRS). IV experience |
| Meeting Title: | 41st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 23 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2005 May 13-17 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2005-06-01 |
| Start Page: | 800S |
| Language: | English |
| ACCESSION: | WOS:000230326605244 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2005.23.16_suppl.8501 |
| Notes: | --- - Meeting Abstract: 8501 - 41st Annual Meeting of the American-Society-of-Clinical-Oncology - MAY 13-17, 2005 - Orlando, FL - S - "1" - "Source: Wos" |
